英文名稱 |
中文名稱 |
CAS號 |
操作 |
Abiraterone |
17-(3-吡啶基)-雄甾-5,16-二烯-3β–醇;阿比特龍雜質(zhì)B |
154229-19-3 |
詳細(xì)
|
Olaparib |
奧拉帕利 |
763113-22-0 |
詳細(xì)
|
Nintedanib Ethanesulfonate Salt |
乙磺酸尼達(dá)尼布 |
656247-18-6 |
詳細(xì)
|
(S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate |
(S)-2-(4-(3-氯-4-氟苯基氨基)-7-(四氫呋喃-3-基氧基)喹唑啉-6-基氨基)-2-氧代乙基膦酸二乙酯 |
618061-76-0 |
詳細(xì)
|
Alectinib hydrochloride |
阿來替尼 |
1256589-74-8 |
詳細(xì)
|
5'-Deoxy-5-fluorocytidine |
卡培他濱雜質(zhì)A |
66335-38-4 |
詳細(xì)
|
4-QuinazolinaMine |
4-[(3-氯-4-氟苯基)氨基]-6-硝基-7-((S)-四氫呋喃-3-基氧基)-喹唑啉 |
314771-88-5 |
詳細(xì)
|
1-(4-cyano-3-(trifluoroMethyl)phenyl)-3-(3-cyano-4-(trifluoroMethyl)phenyl)thiourea |
恩扎盧胺雜質(zhì);1,3-雙-(4-氰基-3-三氟甲基-苯基)-硫脲 |
1415564-70-3 |
詳細(xì)
|
Palbociclib impurity E |
6-溴-8-環(huán)戊基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮 |
851067-56-6 |
詳細(xì)
|
4-[1-(4-cyano-3-trifluoromethyl-phenylcarbamoyl)-1-methyl-ethylamino]-2-fluoro-N- |
恩扎盧胺雜質(zhì) |
1289942-55-7 |
詳細(xì)
|
3-Amino-4-methylbenzoic acid |
3-氨基-4-甲基苯甲酸;尼洛替尼雜質(zhì)H |
2458-12-0 |
詳細(xì)
|
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, hydrochloride, hydrate (1:1:2) |
尼洛替尼單鹽二水 |
923289-71-8 |
詳細(xì)
|
6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, methanesulfonate, compd. with 1,1′-sulfinylbis[methane] (1:1:) |
侖伐替尼甲磺酸鹽DMSO溶劑化物 |
917572-43-1 |
詳細(xì)
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide |
瑞博西尼雜質(zhì)A |
1139453-98-7 |
詳細(xì)
|
Carfilzomib |
卡非佐米 |
868540-17-4 |
詳細(xì)
|
Lapatinib impurity A;2-chloro-4-((6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-yl)amino)phenol |
拉帕替尼雜質(zhì) |
1268997-70-1 |
詳細(xì)
|
Ribociclib |
瑞博西尼 |
1374639-79-8 |
詳細(xì)
|
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
德拉沙星 |
442526-91-2 |
詳細(xì)
|
Capecitabine |
卡培他濱 |
154361-50-9 |
詳細(xì)
|
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
尼達(dá)尼布雜質(zhì)B |
2093243-16-2 |
詳細(xì)
|
Lapatinib impurity E;N-(3-chloro-4-((4-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) |
拉帕替尼雜質(zhì) |
1026818-86-9 |
詳細(xì)
|
Lapatinib impurity H;Lapatinib Impurity 4 |
N-(3-氯-4-((3-氟芐基)氧基)苯基)-6-(5-((5-(4-((3-氯-4-((3-氟芐基)氧基)苯基)氨基)喹唑啉-6-基)呋喃-2-基)甲基)(2-(甲磺酰基)乙基)氨基)甲基)呋喃-2-基)喹唑啉-4-胺 |
2172855-57-9 |
詳細(xì)
|
Regorafenib Impurity |
4-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-氟苯氧基]苯氧基]-N-甲基吡啶酰胺;瑞戈非尼雜質(zhì)I |
2098799-13-2 |
詳細(xì)
|
Oseltamivir phosphate |
磷酸奧司他韋 |
204255-11-8 |
詳細(xì)
|
Lapatinib impurity B;N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
拉帕替尼雜質(zhì)O |
697299-82-4 |
詳細(xì)
|
Afatinib diMaleate |
雙馬來酸鹽阿法替尼 |
850140-73-7 |
詳細(xì)
|
BIBF 1202 |
尼達(dá)尼布雜質(zhì)A |
894783-71-2 |
詳細(xì)
|
Lapatinib impurity I;Lapatinib impurity P |
拉帕替尼雜質(zhì)P |
633370-23-7 |
詳細(xì)
|
Neratinib |
來那替尼 |
698387-09-6 |
詳細(xì)
|
Lapatinib ditosylate |
二甲苯磺酸拉帕替尼 |
388082-78-8 |
詳細(xì)
|
Regorafenib |
瑞戈非尼 |
755037-03-7 |
詳細(xì)
|
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
尼達(dá)尼布雜質(zhì)G |
262368-30-9 |
詳細(xì)
|
Lapatinib impurity F;Lapatinib IMpurity 8 |
5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-呋喃甲醇 |
320337-48-2 |
詳細(xì)
|
Afatinib impurity;Ethyl hydrogen (2-((4-((3-chloro-4-fluorophenyl)amino) -7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate |
(2-((4-((3-氯-4-氟苯基)氨基)-7-(((S)四氫呋喃-3-基)氧基-6-喹唑啉基)氨基)-2-乙氧基)膦酸單乙酯 |
1680184-59-1 |
詳細(xì)
|
(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate |
阿比特龍雜質(zhì)J |
|
詳細(xì)
|
Rucaparib |
瑞卡帕布 |
1327258-57-0 |
詳細(xì)
|
relugolix impurity |
6-(6-氨基苯基)-1-(2,6-二氟芐基)-5-(二甲氨基)甲基-3-(6-甲氧基噠嗪-3-基)噻吩[2,3-d]嘧啶-2,4(1H,3H)-二酮 |
1589503-93-4 |
詳細(xì)
|
Abiraterone Impurity |
17-(3-吡啶基)雄甾-5,16-二烯-3β-(2-四氫吡喃基)-醇;阿比特龍雜質(zhì)D |
1431753-70-6 |
詳細(xì)
|
AKOS BB-3093 |
3-氨基-4-甲基苯甲酸乙酯;尼洛替尼雜質(zhì)G |
41191-92-8 |
詳細(xì)
|
Capecitabine-2',3'-cyclic Carbonate |
卡培他濱雜質(zhì)F |
921769-65-5 |
詳細(xì)
|
Cabazitaxel |
卡巴他賽 |
183133-96-2 |
詳細(xì)
|
Crisaborole |
克立硼羅 |
906673-24-3 |
詳細(xì)
|
5-(piperazin-1-yl)pyridin-2-aMine |
5-(哌嗪-1-基)吡啶-2-胺;哌柏西利雜質(zhì)A |
1082876-26-3 |
詳細(xì)
|
lenvatinib Mesylate |
甲磺酸侖伐替尼 |
857890-39-2 |
詳細(xì)
|
relugolix |
瑞盧戈利 |
737789-87-6 |
詳細(xì)
|
Enzalutamide |
恩扎盧胺 |
1242137-16-1 |
詳細(xì)
|
Enzalutamide carboxylic acid |
恩扎盧胺雜質(zhì)I |
1242137-15-0 |
詳細(xì)
|
Palbociclib impurity D |
4-[6-[(6-乙酰基-8-環(huán)戊基-7,8-二氫-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯 |
1651214-74-2 |
詳細(xì)
|
Abiraterone Impurity |
17-(4-吡啶基)-雄甾-5,16-二烯-3β–乙酸酯;阿比特龍雜質(zhì)F |
165334-69-0 |
詳細(xì)
|
Doxifluridine |
卡培他濱雜質(zhì)B |
3094-09-5 |
詳細(xì)
|
Dasatinib |
達(dá)沙替尼 |
302962-49-8 |
詳細(xì)
|
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE |
4-(4-氨基-3-氟苯氧基)-N-甲基吡啶酰胺;瑞戈非尼雜質(zhì)B |
757251-39-1 |
詳細(xì)
|
5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine |
卡培他濱雜質(zhì)E |
910129-15-6 |
詳細(xì)
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]- |
8-環(huán)戊基-5-甲基-2-[[(5-哌嗪-1-基吡啶-2-基)]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮;哌柏西利雜質(zhì)B |
571190-22-2 |
詳細(xì)
|
Palbociclib impurity G |
8-環(huán)戊基-5-甲基-2-(((5-(哌嗪-1-基)吡啶-2-基)氨基)-6-乙烯基吡啶并[2,3-d]嘧啶-7(8H)-酮 |
2204863-06-7 |
詳細(xì)
|
Afatinib impurity;Afatinib Impurity des-EJA |
(S,E)-N-(4-(3-氯-4-氟苯基胺基)-7-((四氫呋喃-3-基)氧基)-6-喹唑啉)-2-丁烯酰胺 |
2223677-64-1 |
詳細(xì)
|
N,N''-Bis[3-(trifluoromethyl-4-cyanophenyl]urea |
恩扎盧胺雜質(zhì)J |
1895865-11-8 |
詳細(xì)
|
Afatinib impurity; |
(E)-N-(4-((3-氯-4-氟苯基)胺)-7-乙氧基喹唑啉-6-基)-4-(二甲氨基)丁-2-烯酰胺 |
2085843-51-0 |
詳細(xì)
|
Irinotecan hydrochloride trihydrate |
鹽酸伊立替康 |
136572-09-3 |
詳細(xì)
|
Lapatinib impurity J;3-Chloro-4-(3-fluorobenzyloxy)aniline |
3-氯-4-(3-氟芐氧基)苯胺 |
202197-26-0 |
詳細(xì)
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;尼洛替尼雜質(zhì)A |
641569-94-0 |
詳細(xì)
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester |
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;尼洛替尼雜質(zhì)E |
917392-54-2 |
詳細(xì)
|
Afatinib |
阿法替尼 |
850140-72-6 |
詳細(xì)
|
ABT-199 |
維奈妥拉 |
1257044-40-8 |
詳細(xì)
|
Afatinib impurity;(R,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide |
(R,E)-N-{4-[(3-氯-4-氟苯基)氨基]-7-[(四氫呋喃-3-基)氧基]喹唑啉-6-基}-4-(二甲基氨基)丁-2-烯酰胺 |
945553-91-3 |
詳細(xì)
|
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
尼達(dá)尼布雜質(zhì)C |
2097505-01-4 |
詳細(xì)
|
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate |
阿比特龍雜質(zhì)k |
1239-13-6 |
詳細(xì)
|
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide |
4-[3-氟-4-[[2-(甲基氨基甲?;?吡啶-4-基]氨基]苯氧基]-N-甲基吡啶酰胺;瑞戈非尼雜質(zhì)D |
1855006-12-0 |
詳細(xì)
|
Lapatinib impurity D;N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
N-(3-氯-4-((2-氟芐氧基)苯基)-6-(5-(((2-(甲磺?;?乙基)胺)甲基)呋喃-2-基)喹唑啉-4-胺 |
1393112-45-2 |
詳細(xì)
|
Lapatinib impurity G;5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde |
5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉]-2-呋喃甲醛 |
231278-84-5 |
詳細(xì)
|
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine |
N4-(3-氯-4-氟苯基)-7-[[(3S)-四氫-3-呋喃基]氧基]-4,6-喹唑啉二胺 |
314771-76-1 |
詳細(xì)
|
Tedizolid Phosphate |
磷酸特地唑胺 |
856867-55-5 |
詳細(xì)
|
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide |
4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(5-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺;尼洛替尼雜質(zhì)C |
641571-15-5 |
詳細(xì)
|
NILOTINIB IMPURITY |
4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-乙基基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺;尼洛替尼雜質(zhì)F |
2119583-24-1 |
詳細(xì)
|
4-Amino-3-fluorophenol |
4-氨基-3氟苯酚;瑞戈非尼雜質(zhì)A |
399-95-1 |
詳細(xì)
|
Palbociclib impurity C |
6-乙?;?8-環(huán)己基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮;哌柏西利雜質(zhì)C |
|
詳細(xì)
|
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine |
卡培他濱雜質(zhì)C |
161599-46-8 |
詳細(xì)
|
Abiraterone acetate |
醋酸阿比特龍 |
154229-18-2 |
詳細(xì)
|
brivaracetam |
布瓦西坦 |
357336-20-0 |
詳細(xì)
|
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine |
卡培他濱雜質(zhì)D |
162204-30-0 |
詳細(xì)
|
Pemetrexed Disodium Heptahydrate |
培美曲塞七水物 |
357166-29-1 |
詳細(xì)
|
Roxadustat |
羅沙司他 |
808118-40-3 |
詳細(xì)
|
FLUCOFURON |
1-[4-氯-3-(三氟甲基)苯基]-3-[4-氯-3-(三氟甲基)苯基]脲;瑞戈非尼雜質(zhì)F |
370-50-3 |
詳細(xì)
|
Lenvatinib Impurity |
侖伐替尼雜質(zhì)N |
2143930-77-0 |
詳細(xì)
|
Bortezomib |
硼替佐米 |
179324-69-7 |
詳細(xì)
|
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-hydroxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea |
瑞盧戈利雜質(zhì) |
1801551-07-4 |
詳細(xì)
|
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]- |
4-甲基-3-((5-氯-4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺;尼洛替尼雜質(zhì)D |
2469039-94-7 |
詳細(xì)
|
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺;尼洛替尼雜質(zhì)B |
641571-11-1 |
詳細(xì)
|
Sorafenib tosylate |
索拉非尼FORMI |
475207-59-1 |
詳細(xì)
|
Apalutamide |
阿帕魯胺 |
956104-40-8 |
詳細(xì)
|
Elagolix Sodium |
依拉格力 |
832720-36-2 |
詳細(xì)
|
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine |
恩扎盧胺雜質(zhì)P |
1289942-66-0 |
詳細(xì)
|
1-Piperazinecarboxylic acid, 4-[6-[[7-cyclopentyl-6-[(diMethylaMino)carbonyl]-7H-pyrrolo[2,3-d]pyriMidin-2-yl]aMino]-3-pyridinyl]-, 1,1-diMethylethyl ester |
瑞博西尼雜質(zhì)E |
1374639-78-7 |
詳細(xì)
|
4-Amino-2-(trifluoromethyl)benzonitrile |
恩扎盧胺雜質(zhì);4-氨基-2-三氟甲基-芐腈 |
654-70-6 |
詳細(xì)
|
Oxo Enzalutamide |
恩扎盧胺雜質(zhì) |
1242137-18-3 |
詳細(xì)
|
Enzalutamide Impurity 9 |
恩扎盧胺雜質(zhì) |
1895865-10-7 |
詳細(xì)
|
4-Dimethylaminopyridine |
4-二甲氨基吡啶;阿比特龍雜質(zhì)I |
1122-58-3 |
詳細(xì)
|